Cargando…
Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change?
BACKGROUND: Post hoc analyses from clinical trials in Alzheimer's disease (AD) suggest that more cognitively impaired participants respond differently from less impaired on cognitive outcomes. We examined pooled clinical trials data to assess the utility of enriching trials using baseline cogni...
Autores principales: | Kennedy, Richard E., Cutter, Gary R., Wang, Guoqiao, Schneider, Lon S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040516/ https://www.ncbi.nlm.nih.gov/pubmed/27695707 http://dx.doi.org/10.1016/j.trci.2015.03.001 |
Ejemplares similares
-
Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment
por: Wang, Guoqiao, et al.
Publicado: (2015) -
Using practice effects for targeted trials or sub-group analysis in Alzheimer’s disease: How practice effects predict change over time
por: Wang, Guoqiao, et al.
Publicado: (2020) -
Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2018) -
Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2022) -
How does dentistry move from survival to revival?
por: Westgarth, David
Publicado: (2020)